O	0	8	Benefits
O	9	11	in
O	12	19	radical
O	20	30	mastectomy
O	31	39	protocol
O	39	40	:
O	41	42	a
O	43	53	randomized
O	54	59	trial
O	60	70	evaluating
O	71	74	the
O	75	78	use
O	79	81	of
O	82	90	regional
O	91	101	anesthesia
O	101	102	.

O	103	110	Surgery
O	111	113	is
O	114	117	the
O	118	123	first
O	123	124	-
O	124	128	line
O	129	138	treatment
O	139	142	for
O	143	148	early
O	148	149	,
O	150	159	localized
O	159	160	,
O	161	163	or
O	164	172	operable
O	173	179	breast
O	180	186	cancer
O	186	187	.

O	188	196	Regional
O	197	207	anesthesia
O	208	214	during
O	215	225	mastectomy
O	226	229	may
O	230	235	offer
O	236	239	the
O	240	250	prevention
O	251	253	of
B-condition	254	267	postoperative
I-condition	268	272	pain
O	272	273	.

O	274	277	One
O	278	287	potential
O	288	296	protocol
O	297	299	is
O	300	303	the
O	304	315	combination
O	316	318	of
O	319	327	serratus
O	328	336	anterior
O	337	342	plane
O	343	348	block
O	349	350	(
O	350	353	SAM
O	354	359	block
O	359	360	)
O	361	365	with
O	366	374	pectoral
O	375	380	nerve
O	381	386	block
O	387	388	I
O	389	390	(
O	390	394	PECS
O	395	396	I
O	396	397	)
O	397	398	,
O	399	402	but
O	403	406	the
O	407	414	results
O	415	418	and
O	419	428	potential
O	429	437	benefits
O	438	441	are
O	442	449	limited
O	449	450	.

O	451	454	Our
O	455	460	study
O	461	469	compared
O	470	477	general
O	478	488	anesthesia
O	489	493	with
O	494	496	or
O	497	504	without
O	505	508	SAM
O	509	514	block
O	515	516	+
O	517	521	PECS
O	522	523	I
O	524	530	during
O	531	538	radical
O	539	549	mastectomy
O	550	554	with
O	555	563	axillary
O	564	568	node
O	569	579	dissection
O	580	583	and
O	584	590	breast
O	591	605	reconstruction
O	606	611	using
O	612	623	evaluations
O	624	626	of
O	627	631	pain
O	631	632	,
O	633	639	opioid
O	640	651	consumption
O	651	652	,
O	653	657	side
O	658	665	effects
O	666	669	and
O	670	675	serum
O	676	682	levels
O	683	685	of
O	686	697	interleukin
O	698	699	(
O	699	701	IL
O	701	702	)
O	702	703	-
O	703	708	1beta
O	708	709	,
O	710	712	IL
O	712	713	-
O	713	714	6
O	715	718	and
O	719	721	IL
O	721	722	-
O	722	724	10
O	724	725	.

O	726	730	This
O	731	733	is
O	734	735	a
O	736	747	prospective
O	747	748	,
O	749	759	randomized
O	760	770	controlled
O	771	776	trial
O	776	777	.

B-total-participants	778	783	Fifty
I-total-participants	784	792	patients
O	793	797	were
O	798	808	randomized
O	809	811	to
B-control	812	819	general
I-control	820	830	anesthesia
I-control	831	835	only
O	836	838	or
B-intervention	839	846	general
I-intervention	847	857	anesthesia
I-intervention	858	868	associated
I-intervention	869	873	with
I-intervention	874	877	SAM
I-intervention	878	883	block
I-intervention	884	885	+
I-intervention	886	890	PECS
I-intervention	891	892	I
O	893	894	(
B-intervention-participants	894	896	25
O	897	900	per
O	901	906	group
O	906	907	)
O	907	908	.

O	909	912	The
O	913	924	association
O	925	927	of
O	928	931	SAM
O	932	937	block
O	938	939	+
O	940	944	PECS
O	945	946	I
O	947	951	with
O	952	959	general
O	960	970	anesthesia
O	971	978	reduced
B-outcome	979	993	intraoperative
I-outcome	994	1002	fentanyl
I-outcome	1003	1014	consumption
O	1014	1015	,
B-outcome	1016	1024	morphine
I-outcome	1025	1028	use
O	1029	1032	and
B-outcome	1033	1039	visual
I-outcome	1040	1046	analog
I-outcome	1047	1051	pain
I-outcome	1052	1057	scale
I-outcome	1058	1064	scores
O	1065	1067	in
O	1068	1071	the
O	1072	1076	post
O	1076	1077	-
O	1077	1087	anesthetic
O	1088	1092	care
O	1093	1097	unit
O	1098	1099	(
O	1099	1103	PACU
O	1103	1104	)
O	1105	1108	and
O	1109	1111	at
O	1112	1114	24
O	1115	1116	h
O	1117	1122	after
O	1123	1130	surgery
O	1130	1131	.

O	1132	1134	In
O	1135	1143	addition
O	1143	1144	,
O	1145	1148	the
O	1149	1159	anesthetic
O	1160	1168	protocol
O	1169	1178	decreased
B-outcome	1179	1183	side
I-outcome	1184	1191	effects
I-outcome	1192	1195	and
I-outcome	1196	1204	sedation
O	1205	1207	24
O	1208	1209	h
O	1210	1215	after
O	1216	1223	surgery
O	1224	1232	compared
O	1233	1235	to
O	1236	1244	patients
O	1245	1248	who
O	1249	1258	underwent
O	1259	1266	general
O	1267	1277	anesthesia
O	1278	1282	only
O	1282	1283	.

B-outcome	1284	1286	IL
I-outcome	1286	1287	-
I-outcome	1287	1288	6
I-outcome	1289	1295	levels
O	1296	1305	increased
O	1306	1311	after
O	1312	1315	the
O	1316	1323	surgery
O	1324	1332	compared
O	1333	1335	to
O	1336	1344	baseline
O	1345	1351	levels
O	1352	1354	in
O	1355	1359	both
O	1360	1366	groups
O	1366	1367	,
O	1368	1371	and
O	1372	1374	no
O	1375	1386	differences
O	1387	1389	in
O	1390	1392	IL
O	1392	1393	-
O	1393	1395	10
O	1396	1399	and
O	1400	1402	IL
O	1402	1403	-
O	1403	1404	1
O	1405	1409	beta
O	1410	1416	levels
O	1417	1421	were
O	1422	1430	observed
O	1430	1431	.

O	1432	1435	Our
O	1436	1444	protocol
O	1445	1453	improved
O	1454	1457	the
O	1458	1466	outcomes
O	1467	1469	of
O	1470	1480	mastectomy
O	1480	1481	,
O	1482	1487	which
O	1488	1497	highlight
O	1498	1501	the
O	1502	1512	importance
O	1513	1515	of
O	1516	1525	improving
O	1526	1536	mastectomy
O	1537	1546	protocols
O	1547	1550	and
O	1551	1559	focusing
O	1560	1562	on
O	1563	1566	the
O	1567	1575	benefits
O	1576	1578	of
O	1579	1587	regional
O	1588	1598	anesthesia
O	1598	1599	.
